Pharmaceutical Care Management Association issued the following announcement on April 11.
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the House Energy and Commerce Health Subcommittee’s hearing Combating the Opioid Crisis:
Improving the Ability of Medicare and Medicaid to Provide Care For Patients and the discussion of S. 2460 / H.R. 3528 the Every Prescription Conveyed Securely Act:
“Electronic prescribing (e-prescribing) for controlled substances is one of the single most important innovations to reduce opioid abuse. It’s been a proven success in New York State and is likely one of the few solutions on the table that will score savings.
E-prescribing helps ensure each prescription is written by a legitimate provider and filled at a legitimate pharmacy. This solution attacks the opioid epidemic by preventing doctor shopping, drugstore shopping, and fraud. PCMA supports bipartisan legislation that would require e-prescribing of controlled substances in Medicare.”
Original source can be found here.